Log in to save to my catalogue

Breast Cancer; Tamoxifen-treated breast cancer may influence progression of atypical endometrial les...

Breast Cancer; Tamoxifen-treated breast cancer may influence progression of atypical endometrial les...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_209157537

Breast Cancer; Tamoxifen-treated breast cancer may influence progression of atypical endometrial lesions

About this item

Full title

Breast Cancer; Tamoxifen-treated breast cancer may influence progression of atypical endometrial lesions

Publisher

Atlanta: NewsRx

Journal title

Science Letter, 2006, p.189

Language

English

Publication information

Publisher

Atlanta: NewsRx

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The investigators reported, "Progression from complex hyperplasia to complex atypical hyperplasia (1 patient) and from complex and simple hyperplasia to adenocarcinomas (2 patients) was found within 24 months of tamoxifen intake in 3 patients (12.5%). In 2 patients (8.3%), a progression from simple to complex hyperplasia was detected within 36 mont...

Alternative Titles

Full title

Breast Cancer; Tamoxifen-treated breast cancer may influence progression of atypical endometrial lesions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_209157537

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_209157537

Other Identifiers

ISSN

1538-9111

E-ISSN

1538-9162

How to access this item